Get started
Author

Maximiliano Van Kooten

Observed names: M Van Kooten, M van Kooten, M. Van Kooten, M. van Kooten, MAXIMILIANO VAN KOOTEN, Maximiliano van Kooten
Observed institutions: Eli Lilly (United States), Hospital de Clínicas de Porto Alegre, Instituto Alexander Fleming, Hospital Dipreca, Hospital Alemán, Faculdade de Medicina do ABC, Eli Lilly (Australia)
OpenAlex ID: A5073105004
Erlotinib in Previously Treated Non–Small-Cell Lung Cancer
2005 · Frances A. Shepherd, José Rodrigues Pereira, et al. · New England Journal of Medicine · 5,447
PDF
A Randomized Phase 3 Trial Comparing Pemetrexed/Carboplatin and Docetaxel/Carboplatin as First-Line Treatment for Advanced, Nonsquamous Non-small Cell Lung Cancer
2011 · José Rodrigues-Pereira, Joo-Hang Kim, et al. · Journal of Thoracic Oncology · 94
A Systematic Review of the Interobserver Variability for Histology in the Differentiation between Squamous and Nonsquamous Non-small Cell Lung Cancer
2010 · Daniel C. Paech, Adèle R. Weston, et al. · Journal of Thoracic Oncology · 45
PDF
A randomised phase II study of oxaliplatin alone versus oxaliplatin combined with 5-fluorouracil and folinic acid (Mayo Clinic regimen) in previously untreated metastatic colorectal cancer patients
2001 · A. Zori Comba, C. Blajman, et al. · European Journal of Cancer · 37
Histology as a treatment effect modifier in advanced non‐small cell lung cancer: A systematic review of the evidence
2011 · LACHLAN STANDFIELD, ADÈLE R. WESTON, et al. · Respirology · 35
Smoking History as a Predictive Factor of Treatment Response in Advanced Non–Small-Cell Lung Cancer: A Systematic Review
2011 · Paul Mitchell, Tony Mok, et al. · Clinical Lung Cancer · 31
Single-agent gemcitabine in pretreated patients with non-small-cell lung cancer: results of an Argentinean multicentre phase II trial
1999 · M Van Kooten, G Traine, et al. · British Journal of Cancer · 23
PDF
Neoadjuvant Chemotherapy with Gemcitabine and Cisplatin in Stage IIIA/B Non-Small Cell Lung Cancer
2002 · Maximiliano Van Kooten, Moisés Rosenberg, et al. · Investigational New Drugs · 12
Gemcitabine administered as a short infusion versus a fixed dose rate in combination with cisplatin for the treatment of patients with advanced non-small cell lung cancer
2007 · Jose R. Pereira, Luis Fein, et al. · Lung Cancer · 11
Influence of Apoptosis and Cell Cycle Regulator Proteins on Chemotherapy Response and Survival in Stage IIIA/IIIB NSCLC Patients
2007 · José L. Morero, Claudia Poleri, et al. · Journal of Thoracic Oncology · 11
Gemcitabine (GEM) + oxaliplatin (OX) in patients (pts) with stage III/IV ovarian cancer following 3 cycles of carboplatin (CB) + paclitaxel (PAC): Preliminary report of a phase II study
2004 · R. Arca, J. Ibarra, et al. · Journal of Clinical Oncology · 6
Phase II study of induction chemotherapy with gemcitabine (Gemtro®) (G) and cisplatin (C) in patients (pts) with stage IIIA–IIIB non-small cell lung cancer (NSCLC)
2000 · M van Kooten, M Rosenberg, et al. · Lung Cancer · 3
Abstract C31: Phase 1 study of AV-412, a novel irreversible EGFR inhibitor, administered daily in patients with advanced solid tumors
2009 · Pankaj Bhargava, Dan Laheru, et al. · Molecular Cancer Therapeutics · 1
PD5-2-7: Hiperfractionated (HFRT) versus Standard Radiotherapy (SRT) in Locally Advanced (LA) NSCLC: a metaanalysis of randomized phase III trials
2007 · Federico Nasroulah, Juan M. O'connor, et al. · Journal of Thoracic Oncology · 1
PDF
Pemetrexed and carboplatin versus docetaxel and carboplatin as first-line treatment for patients with advanced, non-squamous, non-small cell lung cancer (NSCLC).
2011 · Vinod Ganju, José Rodrigues Pereira, et al.
Randomized phase II study of cisplatin plus gemcitabine administered either as short infusion or at a fixed dose rate in non-small cell lung cancer (NSCLC)
2006 · J. R. Pereira, L. Fein, et al. · Journal of Clinical Oncology
9 Neoadjuvant chemotherapy in non small cell lung cancer (NSCLC):A retrospective evaluation of a single institution experience
2005 · C. Martin, J. Oconors, et al. · Lung Cancer
418 Paclitaxel (Ptx) and cisplatin (cDDDp) as neoadjuvant treatment in stage III non-small-cell lung cancer (NSCLC)
1997 · M. van Kooten, M. Rosenberg, et al. · Lung Cancer
Works count: 18
Citation count: 5,757
H-index: 10
I10-index: 10
Year
Topic
Type